✦ LIBER ✦

Is Prednisolone as Good as Flutamide in Hormone Refractory Metastatic Carcinoma of the Prostate?

✍ Scribed by Datta, S.N.; Thomas, K.; Matthews, P.N.

Book ID: 123361083
Publisher: Lippincott Williams and Wilkins
Year: 1997
Tongue: English
Weight: 321 KB
Volume: 158
Category: Article
ISSN: 0022-5347
DOI: 10.1097/00005392-199707000-00056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of flutamide in hormone-refracto

The use of flutamide in hormone-refractory metastatic prostate cancer

✍ D. G. McLeod; R. C. Benson Jr; M. A. Eisenberger; E. D. Crawford; B. A. Blumenst 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

The use of flutamide as a single antiand

The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer

✍ W.R. Pitts Jr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Antitumor activity of suramin in hormone

Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables

✍ Nancy A. Dawson; Michael R. Cooper; William D. Figg; Donna J. Headlee; Alain Thi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 965 KB

High dose intravenous oestrogen (fosfest

High dose intravenous oestrogen (fosfestrol) in the treatment of symptomatic, metastatic, hormone-refractory carcinoma of the prostate

✍ M. Ahmed; S. Choksy; C. P. Chilton; K. W. Munson; J. H. Williams 📂 Article 📅 1998 🏛 Springer Netherlands 🌐 English ⚖ 334 KB

Phase II trial of single-agent weekly do

Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate

✍ William Berry; Shaker Dakhil; Mary A Gregurich; Lina Asmar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 796 KB

A Phase II study of oral idarubicin as a

A Phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time

✍ Hans-Peter Schmid; Rudolf Maibach; Juerg Bernhard; Franz Hering; Silvia Hanselma 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Background: Treatment of hormone-refractory prostate carcinoma with chemotherapy is purely palliative, and reported response rates have been low. at the time this study was conducted, there was an urgent need for a trial using potentially efficacious drugs, with quality of life (ql), and serial